This report contains market size and forecasts of Respiratory Syncytial Virus (RSV) Diagnostics in Global, including the following market information:
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Respiratory Syncytial Virus (RSV) Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus (RSV) Diagnostics include Roche, AstraZeneca, Merck, AbbVie, Bausch Health, GlaxoSmithKline, ReViral, Gilead Sciences and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Syncytial Virus (RSV) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, by Type, 2021 (%)
Molecular Diagnosis
Rapid Antigen Testing
Other
Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Laborary
Other
Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus (RSV) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus (RSV) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
AstraZeneca
Merck
AbbVie
Bausch Health
GlaxoSmithKline
ReViral
Gilead Sciences
Teva Pharmaceutical